Solid Pancreatic Lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged >=18 years; 2. Patients with solid pancreatic lesions requiring endoscopic ultrasound (EUS) examination; 3. Patients with the ability to read, understand, and sign the informed consent form; 4. Patients who, in the opinion of the investigators, are able to understand the procedures of this clinical study and are willing and able to comply with and complete all study-related procedures.
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding women; 2. History of drug or alcohol abuse, or psychiatric disorders within the past five years; 3. Patients with absolute contraindications to endoscopic ultrasound (EUS) examination; 4. Anatomical abnormalities of the upper gastrointestinal tract caused by advanced malignancies; 5. Known acute and severe pharyngeal diseases preventing endoscope insertion; 6. Patients with upper gastrointestinal obstruction; 7. History of allergy to anesthesia; 8. Patients with dysfunction of vital organs such as the heart or lungs; 9. Patients with uncontrolled hypertension; 10. Patients who are unable to cooperate with or complete the EUS examination for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of Differentiating Benign and Malignant Solid Pancreatic Lesions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity of Differentiating Benign and Malignant Solid Pancreatic Lesions;Specificity of Differentiating Benign and Malignant Solid Pancreatic Lesions; | — |
Countries
China
Contacts
Renmin Hospital of Wuhan University